Collections > UNC Scholarly Publications > BioMed Central > EGFR associated expression profiles vary with breast tumor subtype > Gefitinib and carboplatin combinations in breast cancer-derived cell lines. Cells were treated for 72 h with constant ratios of the IC50 doses for both gefitinib and carboplatin. Combination Index (CI) values below one are synergistic, equal to one

Export Metadata